These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34127219)

  • 1. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.
    Zhu X; Yu Z; Feng L; Deng L; Fang Z; Liu Z; Li Y; Wu X; Qin L; Guo R; Zheng Y
    Carbohydr Polym; 2021 Sep; 268():118237. PubMed ID: 34127219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
    Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
    Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration.
    Dian C; Qian Z; Ran M; Yan X; Dian L
    Int J Nanomedicine; 2024; 19():8603-8620. PubMed ID: 39188859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
    Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
    Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α
    Zou Y; Sun Y; Guo B; Wei Y; Xia Y; Huangfu Z; Meng F; van Hest JCM; Yuan J; Zhong Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14905-14913. PubMed ID: 32148016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency.
    Yang L; Zhang Y; Lai Y; Xu W; Lei S; Chen G; Wang Z
    J Colloid Interface Sci; 2025 Jan; 677(Pt B):523-540. PubMed ID: 39154445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress.
    Yu Z; Ma L; Ye S; Li G; Zhang M
    Carbohydr Polym; 2020 May; 236():115972. PubMed ID: 32172827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
    Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer.
    An Q; Shi CX; Guo H; Xie SM; Yang YY; Liu YN; Liu ZH; Zhou CZ; Niu FJ
    Pharm Dev Technol; 2019 Nov; 24(9):1164-1174. PubMed ID: 31340709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
    Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
    Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
    Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
    Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
    Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
    Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging.
    Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP
    Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.